Rob Richardson
VP, Manufacturing
Bio to come.
Recent Posts
- Eyenovia Reports Third Quarter 2023 Financial Results and Provides Business Update November 13, 2023
- Eyenovia Announces FDA Approval of Coastline International as Contract Manufacturer to Initiate Mydcombi Commercial Production November 3, 2023
- Eyenovia to Sponsor Course on Drug Delivery Innovation at IJCAHPO’s 51st Annual Continuing Education (ACE) Program October 30, 2023
Pipeline and Technology
Corporate Address
Eyenovia, Inc.
295 Madison Avenue
Suite 2400
New York, NY 10017
admin@eyenovia.com